Xybion Digital Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Xybion Digital Inc. - overview
Established
1977
Location
Princeton, NJ, US
Primary Industry
Healthcare IT
About
Xybion Digital Inc. , based in the US, specializes in comprehensive digital solutions for laboratories and R&D teams, focusing on compliance management in the life sciences sector through innovative software offerings. Founded in 1977 and headquartered in Princeton, US, Xybion Digital Inc. provides advanced software solutions for laboratories and research teams.
The company was acquired by Instem plc on July 31, 2025, enhancing its capabilities in preclinical research and compliance management. Xybion’s primary offerings include a suite of digital solutions designed for laboratories and compliance management in the life sciences. Its flagship product, Pristima Web, is a preclinical laboratory information management system (LIMS) and quality management system (QMS) that streamlines the entire preclinical lifecycle. Additionally, Xybion offers SEND Submission Services via its Savante platform, ensuring adherence to FDA standards for nonclinical data submissions.
The company serves a diverse clientele, including pharmaceutical firms and contract research organizations across North America, Europe, and Asia-Pacific. Xybion generates revenue through a subscription-based model and service contracts related to its software solutions. Clients typically enter multi-year agreements for implementation, training, and ongoing support. This structure allows for tailored service offerings combining Pristima Web, SEND Submission Services, and quality management consulting, which are designed to optimize operational efficiency and compliance in drug development processes.
Following its acquisition by Instem plc, Xybion plans to leverage its integration with Instem's SaaS platforms to enhance innovation in life sciences software solutions. The acquisition will enable an expanded global reach and improved preclinical R&D capabilities. Future growth will involve the development of new products and services, although specific release dates are not yet disclosed. Additionally, Xybion aims to strengthen its market presence in Europe and Asia-Pacific by 2025, utilizing recent funding to accelerate these initiatives.
Current Investors
Instem plc
Primary Industry
Healthcare IT
Sub Industries
Biotechnology, Healthcare IT, Medical Devices & Equipment, Pharmaceutical Research & Development, Application Integration Software, Analytics & Performance Software
Website
www.xybion.com
Verticals
HealthTech, RegTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Xybion Digital Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Completed | Xybion Digital Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.